These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18799858)

  • 1. HLA-B27 rats develop osteopaenia through increased bone resorption without any change in bone formation.
    Papet I; El Yousfi M; Godin JP; Mermoud AF; Davicco MJ; Coxam V; Breuille D; Obled C
    J Musculoskelet Neuronal Interact; 2008; 8(3):251-6. PubMed ID: 18799858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio.
    Rauner M; Stupphann D; Haas M; Fert I; Glatigny S; Sipos W; Breban M; Pietschmann P
    J Rheumatol; 2009 Jan; 36(1):120-6. PubMed ID: 19040304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased tissue protein synthesis during spontaneous inflammatory bowel disease in HLA-B27 rats.
    El Yousfi M; Breuillé D; Papet I; Blum S; André M; Mosoni L; Denis P; Buffière C; Obled C
    Clin Sci (Lond); 2003 Oct; 105(4):437-46. PubMed ID: 12793856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of bone strength in HLA-B27 transgenic rats is characterized by a high bone turnover and is mainly osteoclast-driven.
    Rauner M; Thiele S; Fert I; Araujo LM; Layh-Schmitt G; Colbert RA; Hofbauer C; Bernhardt R; Bürki A; Schwiedrzik J; Zysset PK; Pietschmann P; Taurog JD; Breban M; Hofbauer LC
    Bone; 2015 Jun; 75():183-91. PubMed ID: 25746795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased bone strength in HLA-B27 transgenic rat model of spondyloarthropathy.
    Akhter MP; Jung LK
    Rheumatology (Oxford); 2007 Aug; 46(8):1258-62. PubMed ID: 17526927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of colorectal cancer in HLA-B27 transgenic F344 rats with chronic inflammatory bowel disease.
    Hammer RE; Richardson JA; Simmons WA; White AL; Breban M; Taurog JD
    J Investig Med; 1995 Jun; 43(3):262-8. PubMed ID: 7614072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells from spondylarthritis-prone HLA-B27-transgenic rats display altered cytoskeletal dynamics, class II major histocompatibility complex expression, and viability.
    Dhaenens M; Fert I; Glatigny S; Haerinck S; Poulain C; Donnadieu E; Hacquard-Bouder C; André C; Elewaut D; Deforce D; Breban M
    Arthritis Rheum; 2009 Sep; 60(9):2622-32. PubMed ID: 19714626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical markers of bone turnover and bone mineral density in patients with beta-thalassaemia major.
    Eren E; Yilmaz N
    Int J Clin Pract; 2005 Jan; 59(1):46-51. PubMed ID: 15707464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered bone material properties in HLA-B27 rats include reduced mineral to matrix ratio and altered collagen cross-links.
    Gamsjaeger S; Srivastava AK; Wergedal JE; Zwerina J; Klaushofer K; Paschalis EP; Tatakis DN
    J Bone Miner Res; 2014 Nov; 29(11):2382-91. PubMed ID: 24771481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B27 transgenic rats are susceptible to accelerated alveolar bone loss.
    Tatakis DN; Guglielmoni P
    J Periodontol; 2000 Sep; 71(9):1395-400. PubMed ID: 11022768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone turnover in untreated polymyalgia rheumatica.
    Barnes TC; Daroszewska A; Fraser WD; Bucknall RC
    Rheumatology (Oxford); 2004 Apr; 43(4):486-90. PubMed ID: 14722347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased bone resorption and osteopenia in Dlx5 heterozygous mice.
    Samee N; Geoffroy V; Marty C; Schiltz C; Vieux-Rochas M; Clément-Lacroix P; Belleville C; Levi G; de Vernejoul MC
    J Cell Biochem; 2009 Aug; 107(5):865-72. PubMed ID: 19415689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of colonic inflammation in HLA-B27 transgenic rats by feeding Marie Ménard apples, rich in polyphenols.
    Castagnini C; Luceri C; Toti S; Bigagli E; Caderni G; Femia AP; Giovannelli L; Lodovici M; Pitozzi V; Salvadori M; Messerini L; Martin R; Zoetendal EG; Gaj S; Eijssen L; Evelo CT; Renard CM; Baron A; Dolara P
    Br J Nutr; 2009 Dec; 102(11):1620-8. PubMed ID: 19622193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated alveolar bone loss in HLA-b27 transgenic rats: an adult onset condition.
    Tatakis DN; Guglielmoni P; Fletcher HM
    J Rheumatol; 2002 Jun; 29(6):1244-51. PubMed ID: 12064843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of energy and casein or whey protein intake on bone status in a rat model of age-related bone loss.
    Mardon J; Zangarelli A; Walrand S; Davicco MJ; Lebecque P; Demigné C; Horcajada MN; Boirie Y; Coxam V
    Br J Nutr; 2008 Apr; 99(4):764-72. PubMed ID: 17925049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.
    Tran TM; Dorris ML; Satumtira N; Richardson JA; Hammer RE; Shang J; Taurog JD
    Arthritis Rheum; 2006 Apr; 54(4):1317-27. PubMed ID: 16575857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral treatment with recombinant human interleukin-11 improves mucosal transport in the colon of human leukocyte antigen-B27 transgenic rats.
    Venkova K; Keith JC; Greenwood-Van Meerveld B
    J Pharmacol Exp Ther; 2004 Jan; 308(1):206-13. PubMed ID: 14569059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose pioglitazone does not affect bone formation and resorption markers or bone mineral density in streptozocin-induced diabetic rats.
    Tsirella E; Mavrakanas T; Rager O; Tsartsalis S; Kallaras K; Kokkas B; Mironidou-Tzouveleki M
    J Physiol Pharmacol; 2012 Apr; 63(2):201-4. PubMed ID: 22653908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human interleukin-11 restores smooth muscle function in the jejunum and colon of human leukocyte antigen-B27 rats with intestinal inflammation.
    Greenwood-Van Meerveld B; Venkova K; Keith JC
    J Pharmacol Exp Ther; 2001 Oct; 299(1):58-66. PubMed ID: 11561063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical markers of bone turnover. New aspect. Biochemical bone markers of bone in patients treated with glucocorticoid].
    Yamauchi M
    Clin Calcium; 2009 Aug; 19(8):1092-1100. PubMed ID: 19638692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.